New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/16204787
Conclusion of this study
These results suggest that ICS improved lung function in COPD patients with moderate airflow obstruction, beside a minor improvement in the oxidant-antioxidant imbalance leading to a lesser expression of ICAM-1. Treatment with NAC decreased some inflammatory parameters and had indirectly an inhibitory effect on the expression of adhesion molecules.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study